Filing Details
- Accession Number:
- 0001735276-22-000039
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-05 16:05:01
- Reporting Period:
- 2022-04-01
- Accepted Time:
- 2022-04-05 16:05:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178670 | Alnylam Pharmaceuticals Inc. | ALNY | Pharmaceutical Preparations (2834) | 770602661 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1237564 | M Steven Paul | 675 West Kendall Street Henri A. Termeer Square Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-04-01 | 15,000 | $11.33 | 16,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-04-01 | 253 | $166.04 | 15,747 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-01 | 4,948 | $168.95 | 10,799 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-01 | 4,872 | $169.71 | 5,927 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-01 | 1,235 | $171.16 | 4,692 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-01 | 1,434 | $172.10 | 3,258 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-01 | 642 | $173.06 | 2,616 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-01 | 90 | $174.33 | 2,526 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-01 | 526 | $176.51 | 2,000 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-01 | 825 | $177.58 | 1,175 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-04-01 | 175 | $178.60 | 1,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-04-01 | 15,000 | $0.00 | 15,000 | $11.33 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-06-21 | 2022-06-21 | No | 4 | M | Direct |
Footnotes
- All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 29, 2021. The 15,000 options exercised and sold by the reporting person were due to expire on June 21, 2022.
- Sale prices ranged from $165.91 to $166.41.
- Sale prices ranged from $168.30 to $169.30.
- Sale prices ranged from $169.32 to $170.28.
- Sale prices ranged from $170.70 to $171.63.
- Sale prices ranged from $171.75 to $172.73.
- Sale prices ranged from $172.83 to $173.37.
- Sale prices ranged from $176.04 to $176.88.
- Sale prices ranged from $177.12 to $178.00.
Billionaire Hedge Funds
